Acrivon Therapeutics, Inc. Common Stock (ACRV) vs Neonc Technologies Holdings, Inc. (NTHI)

A side-by-side comparison of Acrivon Therapeutics, Inc. Common Stock and Neonc Technologies Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Acrivon Therapeutics, Inc. Common Stock logo
ACRV
Acrivon Therapeutics, Inc. Common Stock
$81M
$1.89HealthcareDelayed quote: Oct 6, 2026, 1:19 PM EDT
Neonc Technologies Holdings, Inc. logo
NTHI
Neonc Technologies Holdings, Inc.
$77M
$2.98HealthcareDelayed quote: Oct 6, 2026, 1:13 PM EDT

Total return — ACRV vs NTHI

growth of $100 · dividends reinvested · last 1y
ACRV +45.6% (+45.6%/yr)NTHI -69.7% (-69.7%/yr)ACRV compounded faster over this window
50100150200Start $1002026$146$30
ACRV NTHI

ACRV vs NTHI: by the numbers

  • •ACRV is the larger company ($81M vs $77M market cap).
  • •Both run net losses; ACRV's is the smaller (0.00% vs -155404.38% net margin).

Metrics side by side

Valuation

MetricACRVNTHI
P/B ratio0.93N/A

Profitability

MetricACRVNTHI
Gross margin0.00%100.00%
Operating margin0.00%-145459.36%
Net margin0.00%-155404.38%
ROE-85.65%N/A
ROIC-88.28%N/A

Go deeper

Full ACRV analysisFull NTHI analysisInteractive comparison tool

Dig into the metrics

Acrivon Therapeutics, Inc. Common Stock ROENeonc Technologies ROEAcrivon Therapeutics, Inc. Common Stock operating marginNeonc Technologies operating marginAcrivon Therapeutics, Inc. Common Stock revenue growthNeonc Technologies revenue growthAcrivon Therapeutics, Inc. Common Stock free cash flowNeonc Technologies free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.